loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Germany - Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 SGB V for the active ingredient ustekinumab, ATC L04AC05 for the period from July 1st, 2023 to June 30th, 2025

World Biggest Tenders Source

This tender with title Germany - Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 SGB V for the active ingredient ustekinumab, ATC L04AC05 for the period from July 1st, 2023 to June 30th, 2025 --
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 für die Zeit vom 01.07.2023 - 30.06.2025 has been published on Bidding Source portal dated 22 May 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.


Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 für die Zeit vom 01.07.2023 - 30.06.2025

General Information

Germany

Germany - Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 SGB V for the active ingredient ustekinumab, ATC L04AC05 for the period from July 1st, 2023 to June 30th, 2025

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 für die Zeit vom 01.07.2023 - 30.06.2025
Invitation for Bids
2023/S 096-299545
Germany
Germany-Hamburg
22 May 2023
5 May 2025
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

425595-Awarded - Germany – Pharmaceutical products – Award of medicinal products as of 01.07.2025 Germany 410786- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 409776- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.08.2025 to 31.07.2027 Germany 404114- Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-09 Germany 405165-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM016 - Arzneimittel - Natriumpräparate Germany 400529- Germany – Pharmaceutical products – Drug discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V within the framework of open-house procedures Germany 398866- Germany – Pharmaceutical products – Pharmaceutical contracts with accession option Germany 400431-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Sections 130a (8) and 130c (1) of the Social Code Book V between IKK classic and Outlook Therapeutics Limited for Lytenava Germany 412645-Awarded - Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130c Paragraph 1 SGB V in conjunction with Section 130a Paragraph 8 SGB V for the active ingredient Romosozumab Germany 381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05). Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans